Xenon Pharmaceuticals Inc (XENE)
Retained Earnings
-$1.46B
Quarterly · Period ending: · USD
XENE Retained Earnings
Latest reported-$1.46Bperiod ending
Latest reported-$1.46Bperiod ending
XENE Quarterly Retained Earnings (-$128.78M → -$1.46B)
Quarterly retained earnings
High-resolution chart · PNG
XENE retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -1,458,418,000 | |
| -1,347,682,000 | |
| -1,245,380,000 | |
| -1,140,119,000 | |
| -1,049,223,000 | |
| -964,517,000 | |
| -899,470,000 | |
| -833,785,000 | |
| -770,995,000 | |
| -713,071,000 | |
| -665,140,000 | |
| -620,397,000 | |
| -571,935,000 | |
| -524,474,000 | |
| -482,747,000 | |
| -445,352,000 | |
| -408,202,000 | |
| -377,044,000 | |
| -357,374,000 | |
| -331,810,000 | |
| -316,365,000 | |
| -294,256,000 | |
| -278,492,000 | |
| -266,169,000 | |
| -257,314,000 | |
| -257,139,000 | |
| -249,655,000 | |
| -238,279,000 | |
| -229,408,000 | |
| -219,401,000 | |
| -207,885,000 | |
| -199,327,000 | |
| -184,944,000 | |
| -177,143,000 | |
| -173,388,000 | |
| -165,323,000 | |
| -157,581,000 | |
| -150,201,000 | |
| -142,681,000 | |
| -136,704,000 | |
| -128,972,000 | |
| -122,956,000 | |
| -119,693,000 | |
| -115,754,000 | |
| -111,801,000 | |
| -107,999,000 | |
| -103,734,000 | |
| -104,958,000 | |
| -114,149,000 | |
| 0 | |
| -116,752,000 | |
| -125,644,000 | |
| -125,644,000 | |
| -128,784,000 | |
| -128,784,000 |